These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31589957)

  • 81. PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.
    Li X; Liu H; Zhou X; Zhou Y; Zhang Y; Liou YL; Zeng M; Zhu H
    Clin Epigenetics; 2023 Aug; 15(1):123. PubMed ID: 37533109
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians.
    Chen Y; Cui Z; Xiao Z; Hu M; Jiang C; Lin Y; Chen Y
    Ann Transl Med; 2016 Oct; 4(19):365. PubMed ID: 27826568
    [TBL] [Abstract][Full Text] [Related]  

  • 83. PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
    Luan T; Hua Q; Liu X; Xu P; Gu Y; Qian H; Yan L; Xu X; Geng R; Zeng X; Li P
    Int J Gynecol Cancer; 2017 Sep; 27(7):1480-1488. PubMed ID: 28472814
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
    Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
    [TBL] [Abstract][Full Text] [Related]  

  • 85. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
    Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
    Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.
    Botezatu A; Socolov D; Iancu IV; Huica I; Plesa A; Ungureanu C; Anton G
    J Cell Mol Med; 2013 Apr; 17(4):543-9. PubMed ID: 23444906
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.
    de Freitas Cordeiro-Silva M; Stur E; Agostini LP; de Podestá JR; de Oliveira JC; Soares MS; Mendonça EF; Gouvea SA; Von Zeidler SV; Louro ID
    Mol Biol Rep; 2012 Dec; 39(12):10111-9. PubMed ID: 22936053
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Correlation between Methylation of SALL3 and Cervical Cancer].
    Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
    El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
    [TBL] [Abstract][Full Text] [Related]  

  • 90. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
    Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
    Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Interaction between fragile histidine triad methylation, protein expression and human papillomavirus 16 infection in cervical carcinogenesis].
    Liu XZ; Nan J; Li J; Li Y; Ding L; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):858-62. PubMed ID: 27346116
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
    Singh P; Bhadada SK; Arya AK; Saikia UN; Sachdeva N; Dahiya D; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e783-e792. PubMed ID: 34453169
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
    Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
    Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Detection of DKK-1 gene methylation in exfoliated cells of cervical squamous cell carcinoma and its relationship with high risk HPV infection.
    He YH; Su RJ; Zheng J
    Arch Gynecol Obstet; 2021 Sep; 304(3):743-750. PubMed ID: 33547934
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer.
    Lu X; Lin Q; Lin M; Duan P; Ye L; Chen J; Chen X; Zhang L; Xue X
    PLoS One; 2014; 9(7):e97588. PubMed ID: 24992025
    [TBL] [Abstract][Full Text] [Related]  

  • 96. CXCL12 rs266085 and TNF-α rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population.
    Yin G; Zhu T; Li J; Wu A; Liang J; Zhi Y
    Int J Clin Exp Pathol; 2015; 8(5):5768-74. PubMed ID: 26191295
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Mouse Papillomavirus Epigenetic Signature Is Characterised by DNA Hypermethylation after Lesion Regression.
    Tschirley AM; Stockwell PA; Rodger EJ; Eltherington O; Morison IM; Christensen N; Chatterjee A; Hibma M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696474
    [TBL] [Abstract][Full Text] [Related]  

  • 98. SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.
    Hopman ANH; Moshi JM; Hoogduin KJ; Ummelen M; Henfling MER; van Engeland M; Wouters KAD; Stoop H; Looijenga LHJ; Ramaekers FCS
    Histopathology; 2020 Feb; 76(3):383-393. PubMed ID: 31444787
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.
    Brandsma JL; Sun Y; Lizardi PM; Tuck DP; Zelterman D; Haines GK; Martel M; Harigopal M; Schofield K; Neapolitano M
    Virology; 2009 Jun; 389(1-2):100-7. PubMed ID: 19443004
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.
    Nunobiki O; Sano D; Hata S; Ogasawara T; Ueda M
    Hum Cell; 2018 Apr; 31(2):149-153. PubMed ID: 29362984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.